InvestorsHub Logo

Farmer7

03/16/17 10:57 PM

#72479 RE: moxa1 #72476

Great post! Too add to that owcp has stated there multiple myeloma research/trials is set up to move into FDA orphan drug status at some point!

Del Potro

03/16/17 11:02 PM

#72481 RE: moxa1 #72476

Those FDA protocols cost millions as you say.

Plant extracts do not need approval but still can be tested to prove their worth as many other nutraceuticals.

Right now they are working on getting the cbd extract cremes out.

Worry about the drugs later, right now it isn't relevant so no use even talking about it, it's too far off.

For now buy all you can, you won't have the chance later at these prices.




skitahoe

03/16/17 11:35 PM

#72486 RE: moxa1 #72476

If I understand what they are planning for multi myeloma, they will be adding a cannabis based drug they've developed to SOC drugs already in use. The price of the trials won't be cheap, but hopefully they will be supported by earnings from the psoriasis cream and perhaps others that don't require full efficacy testing.

If the psoriasis cream needed full FDA approved Phase 3 trials, it's cost would be dramatically higher and take years longer.

Gary